Evidence map›Paper›PMID 31788660›Full record

ArticleActa myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology2019

Phenotypic and genetic spectrum of patients with limb-girdle muscular dystrophy type 2A from Serbia.

Stojan Peric, Jelena Stevanovic, Katherine Johnson, Ana Kosac, Marina Peric, Marija Brankovic, Ana Marjanovic, Milena Jankovic, Bojan Banko, Sanja Milenkovic and 7 more

Abstract read
In one paragraph

Article in Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Stojan PericNeurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Serbia.
Jelena StevanovicNeurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Serbia.
Katherine JohnsonThe John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
Ana KosacClinic for Neurology and Psychiatry for Children and Youth, Belgrade, Serbia.
Marina PericMother and Child Health Care Institute, Belgrade, Serbia.
Marija BrankovicNeurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Serbia.
Ana MarjanovicNeurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Serbia.
Milena JankovicNeurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Serbia.
Bojan BankoCenter for Magnetic Resonance Imaging, Clinical Center of Serbia, School of Medicine, University of Belgrade, Serbia.
Sanja MilenkovicClinical-Hospital Center Zemun, Belgrade, Serbia.
Milica DurdicCenter for Magnetic Resonance Imaging, Clinical Center of Serbia, School of Medicine, University of Belgrade, Serbia.
Ivo BozovicNeurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Serbia.
Jelena Nikodinovic GlumacClinic for Neurology and Psychiatry for Children and Youth, Belgrade, Serbia.
Dragana LavrnicThe John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
Ruzica MaksimovicCenter for Magnetic Resonance Imaging, Clinical Center of Serbia, School of Medicine, University of Belgrade, Serbia.
Vedrana Milic-RasicClinic for Neurology and Psychiatry for Children and Youth, Belgrade, Serbia.
Vidosava Rakocevic-StojanovicNeurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Limb-girdle muscular dystrophy (LGMD) type 2A (calpainopathy) is an autosomal recessive disease caused by mutation in the

Indexed as

AdolescentAdultAge of OnsetAllelesBiopsyCalpainChildFemaleGenotypeHumansMagnetic Resonance ImagingMaleMuscle ProteinsMuscular Dystrophies, Limb-GirdleMutationPhenotypeCalpainCAPN3 protein, humanMuscle Proteinsc.550delA mutationcalpainopathymuscle histopathologymuscle magnetic resonance imaging

Identifiers

PMID31788660
PMCPMC6859413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.